Bracco for the Environment - Environmental labeling Our commitment is concrete also on the topic of separate waste collection which allows us to proceed on our path of sustainable development. 

Efficacy and Safety of Gadopiclenol The results of the multicenter, multinational PICTURE clinical trial demonstrate that 0.05 mmol/kg gadopiclenol provides similar morphologic information about CNS lesions and greater contrast enhancement compared with 0.1 mmol/kg gadobutrol.

Whistleblowing Procedures and guidelines for Whistleblowing

The Impact of Seeing the Full Picture Bracco’s standpoint on sustainability - and environmental sustainability in particular - is that it is essential to look at the full picture.

Bracco’s VUEWAY™ (gadopiclenol) injection now in hospitals Preeminent Hospitals and Medical Practices Nationwide Lead in Patient Care with First Use of Bracco’s VUEWAY™ (gadopiclenol) solution for injection for MRI.

Bracco announces the birth of Bracco Japan Ltd Bracco will acquire all shares of Bracco-Eisai held by Eisai and change its name from Bracco-Eisai to Bracco Japan, Ltd.  as of April 1, 2023.

Thank you: We unlocked the invisible together at ECR2023 Official page for Bracco Imaging's participation in the European Congress of Radiology (ECR) 2023. Learn more about our medical imaging solutions and products for cardiology and radiography.

AI and Radiology: mutual game changers At ECR 2023 in Vienna, we discussed what means to be Gamechangers in radiology and how this aligns with the Bracco motto “Unlocking the Invisible”.

JPR 2023 Bracco do Brasil will be present at one of the largest congresses in Latin America with its complete portfolio of diagnostic imaging solutions.

Quantification software VueBox® is a Bracco-patented, general-purpose software application for quantifying tissue perfusion using Dynamic Contrast-Enhanced Ultrasound (DCE-US).